School of Medicine, Minho University
Life and Health Sciences Research Institute (ICVS)
Associate Professor in the School of Medicine, Minho University Researcher in the Life and Health Sciences Research Institute (ICVS), Minho University Recently retired Family Physician Member of the Advisory Board of the Portuguese National Respiratory Diseases Program (PNDR) since 2013 Past President of the International Primary Care Respiratory Group 2016-2018 Past Chair of the Portuguese Primary Care Respiratory group (GRESP) a working party within the APMGF (Portuguese Association of General and Family Medicine) 2010-2015 Society’s Membership: European Respiratory Society (ERS), Portuguese Society of Allergology (SPAIC), Portuguese Society of Pulmonology (SPP), European Academy of Teachers in General Practice / Family Medicine, Portuguese Association of Teachers in Family Medicine (ADSO), Board of Trustees of the National Health Service Foundation (Portugal) Publications: Pubmed: My NCBI, My Bibliography https://www.ncbi.nlm.nih.gov/sites/myncbi/1ZcAgM5Av7oA6/bibliography/40369282/public/?sortby=pubDate&sdirection=descending. ORCID: http://orcid.org/0000-0001-6459-7908

Presenter of 1 Presentation

ASTHMA AND COVID-19

Date
08.07.2021, Thursday
Session Time
05:30 PM - 07:00 PM
Room
Hall 2
Lecture Time
05:30 PM - 05:47 PM
Session Icon
Pure Live

Abstract

Abstract Body

This presentation will provide an update on:

Protection measures for people with asthma. What has been recommended; the impact of lockdown and physical distance on curbing down de pandemic. Have we neglected our asthma patients during the pandemic?

Asthma and COVID-19 risks: adequate asthma control as a means to minimise risk in case of Covid-19 infection. Promoting self-care and remote support to maintain asthma control.

Impact on services: use of remote consultations, diagnosis rates and accuracy. Remote consultations were needed to protect GP and patient during COVID. This will eventually change practice forever. What constitutes a ‘remote respiratory consultation’ and what does it look like now in your experience? When should it be safely done?

Anticipating return to a “new normal”: how to prioritise asthma reviews. How to deal with patients who recovered from Covid 19.

Hide